A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/24 (2006.01) A61K 9/14 (2006.01) C07K 17/00 (2006.01)
Patent
CA 2574085
Antagonistic peptides of GnRH having improved water solubility are disclosed. These peptides are capable of suppressing serum testosterone levels in vivo to chemical castration levels of <=0.5 ng/ml. Stable, filter sterilizable, non- gelling solutions containing the GnRH antagonists at least at levels typically used in sustained release formulations also are disclosed, as is a method of increasing the solubility of GnRH antagonist in a polymer containing dispersed phase, which method comprises addition of an acid to the dispersed phase.
L'invention concerne des peptides antagonistes de la GnRH présentant une meilleure solubilité dans l'eau. Ces peptides peuvent rabaisser les niveaux de testostérone sérique in vivo jusqu'à des niveaux de castration chimique =0,5 ng/ml. L'invention concerne également des solutions stables et stérilisables, sans gélification, contenant les antagonistes de la GnRH au moins à des niveaux habituellement utilisés dans les formulations à libération prolongée, ainsi qu'une méthode d'augmentation de la solubilité d'un antagoniste de la GnRH dans une phase dispersée contenant un polymère, ladite méthode comprenant l'ajout d'un acide dans la phase dispersée.
Murtagh James
Thanoo Bagavathikanun C.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Oakwood Laboratories L.l.c.
LandOfFree
Gonadotropin releasing hormone antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gonadotropin releasing hormone antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gonadotropin releasing hormone antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1935719